Condition
EBV clinical trials and research
As of November 12, 2026, Find a Trial lists 5 EBV clinical trials that are recruiting, at sites in 4 countries (most in United States (2), China (1), Australia (1)). By phase: Phase 1 (2), Phase 2/3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest EBV clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| mRNA EBV vaccine in healthy young adults | Phase 1 | Herston, Queensland and 1 other locations | Recruiting | Apr 29, 2026 |
| Golidocitinib plus selinexor for chronic active Epstein‑Barr virus disease (CAEBVD) | Phase 2/3 | Beijing | Recruiting | Jan 27, 2026 |
| Vaccination against Epstein-Barr Virus in Healthy Adults | Phase 1 | Bethesda, Maryland | Recruiting | Apr 3, 2025 |
| Infusing donor-derived virus-specific T-cells to treat post-transplant viral infections | Phase 2 | Basel | Recruiting | Dec 10, 2013 |
| Understanding severe viral infections in patients without known immune issues | — | Bethesda, Maryland | Recruiting | Nov 11, 2009 |
All recruiting trials (5)
-
mRNA EBV vaccine in healthy young adults
A first-in-human, dose-escalation study will test an mRNA vaccine (VXCO-102) to see if it is safe and can provoke an immune response in healthy 18–25 year olds.
-
Golidocitinib plus selinexor for chronic active Epstein‑Barr virus disease (CAEBVD)
This trial will try combining golidocitinib and selinexor to treat adults aged 18–70 with chronic active Epstein‑Barr virus disease, including EBV‑associated lymphohistiocytosis.
-
Vaccination against Epstein-Barr Virus in Healthy Adults
This study is testing two new vaccines for the Epstein-Barr Virus in healthy adults aged 18 to 29 to see if they can safely boost the immune response against the virus.
-
Infusing donor-derived virus-specific T-cells to treat post-transplant viral infections
This study is testing if infusing special immune cells from donors can help patients who have had a stem cell transplant and are struggling with tough viral infections.
-
Understanding severe viral infections in patients without known immune issues
This study is trying to understand why some healthy people get severe viral infections and how different tests can help figure it out.
Related topics
Quick answers
How many EBV clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), China (1 trial), Australia (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.